Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
4.
J Antimicrob Chemother ; 76(5): 1242-1249, 2021 04 13.
Article in English | MEDLINE | ID: mdl-33569597

ABSTRACT

OBJECTIVES: To describe the impact of extracorporeal membrane oxygenation (ECMO) devices on piperacillin exposure in ICU patients. METHODS: This observational, prospective, multicentre, case-control study was performed in the ICUs of two tertiary care hospitals in France. ECMO patients with sepsis treated with piperacillin/tazobactam were enrolled. Control patients were matched according to SOFA score and creatinine clearance. The pharmacokinetics of piperacillin were described based on a population pharmacokinetic model, calculating the proportion of time the piperacillin plasma concentration was above 64 mg/L (i.e. 4× MIC breakpoint for Pseudomonas aeruginosa). RESULTS: Forty-two patients were included. Median (IQR) age was 60 years (49-66), SOFA score was 11 (9-14) and creatinine clearance was 47 mL/min (5-95). There was no significant difference in the proportion of time piperacillin concentrations were ≥64 mg/L in patients treated with ECMO and controls during the first administration (P = 0.184) or at steady state (P = 0.309). Following the first administration, 36/42 (86%) patients had trough piperacillin concentrations <64 mg/L. Trough concentrations at steady state were similar in patients with ECMO and controls (P = 0.535). Creatinine clearance ≥40 mL/min was independently associated with piperacillin trough concentration <64 mg/L at steady state [OR = 4.3 (95% CI 1.1-17.7), P = 0.043], while ECMO support was not [OR = 0.5 (95% CI 0.1-2.1), P = 0.378]. CONCLUSIONS: ECMO support has no impact on piperacillin exposure. ICU patients with sepsis are frequently underexposed to piperacillin, which suggests that therapeutic drug monitoring should be strongly recommended for severe infections.


Subject(s)
Extracorporeal Membrane Oxygenation , Sepsis , Aged , Anti-Bacterial Agents , Case-Control Studies , France , Humans , Middle Aged , Piperacillin , Prospective Studies , Sepsis/drug therapy
6.
Eur J Clin Microbiol Infect Dis ; 39(4): 629-635, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31773364

ABSTRACT

The optimal timing of cardiac surgery in infective endocarditis (IE) remains debated: Early surgery decreases the risk of embolism, and heart failure, but is associated with an increased rate of positive valve culture. To determine the determinants, and the consequences, of positive valve culture when cardiac surgery is performed during the acute phase of IE, we performed a retrospective study of adult patients who underwent cardiac surgery for definite left-sided IE (Duke Criteria), in two referral centres. During the study period (2002-2016), 148 patients fulfilled inclusion criteria. Median age was 65 years [interquartile range, 53-73], male-to-female ratio was 2.9 (110/38). Cardiac surgery was performed after 14 days [5-26] of appropriate antibiotics. Valve cultures returned positive in 46 cases (31.1%). Factors independently associated with positive valve culture were vegetation size ≥ 10 mm (OR 2.83 [1.16-6.89], P = 0.022) and < 14 days of appropriate antibacterial treatment before surgery (OR 4.68 [2.04-10.7], P < 0.001). Positive valve culture was associated with increased risk of postoperative acute respiratory distress syndrome (37.0% vs. 15.7%, P = 0.008) but was associated neither with an increased risk of postoperative relapse nor with the need for additional cardiac surgery. Duration of appropriate antibacterial treatment and vegetation size are independently predictive of positive valve culture in patients operated during the acute phase of IE. Positive valve culture is associated with increased risk of postoperative acute respiratory distress syndrome.


Subject(s)
Cardiac Surgical Procedures/standards , Endocarditis, Bacterial/microbiology , Endocarditis, Bacterial/surgery , Heart Valves/microbiology , Acute Disease , Aged , Anti-Bacterial Agents/therapeutic use , Bacteria/isolation & purification , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/methods , Colony Count, Microbial , Endocarditis, Bacterial/drug therapy , Female , Humans , Male , Middle Aged , Respiratory Distress Syndrome/etiology , Retrospective Studies , Risk Factors
7.
J Chir (Paris) ; 146(4): 416-8, 2009 Aug.
Article in French | MEDLINE | ID: mdl-19772961

ABSTRACT

Angiomyxoma is a rare but aggressive mesenchymal tumor. It commonly develops in the pelvis, perineum and groin and is more common in females. Angiomyxoma characteristically has a high incidence of local recurrence. The only treatment of recurrence is surgical re-excision. We report a case of recurrent aggressive angiomyxoma, which was only incompletely resected.


Subject(s)
Myxoma/surgery , Pelvic Neoplasms/surgery , Perineum , Adult , Age Factors , Aged , Child , Female , Follow-Up Studies , Humans , Incidence , Magnetic Resonance Imaging , Male , Middle Aged , Myxoma/diagnosis , Myxoma/epidemiology , Myxoma/pathology , Neoplasm Invasiveness , Neoplasm Recurrence, Local , Pelvic Neoplasms/diagnosis , Pelvic Neoplasms/epidemiology , Pelvic Neoplasms/pathology , Sex Factors , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL